DYNAMIS THERAPEUTICS INC has a total of 52 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BABISH JOHN G, BIOTIE THERAPIES INC and INNOVATIVE MED CONCEPTS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | China | 5 | |
#5 | Taiwan | 4 | |
#6 | Australia | 3 | |
#7 | Canada | 3 | |
#8 | Mexico | 3 | |
#9 | Republic of Korea | 2 | |
#10 | South Africa | 2 | |
#11 | Hong Kong | 1 | |
#12 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Microorganisms | |
#5 | Heterocyclic compounds | |
#6 | Pasteurisation | |
#7 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Tobia Annette | 40 |
#2 | Kappler Francis | 32 |
#3 | Schwartz Michael L | 6 |
#4 | Marcy Alice | 5 |
#5 | Su Bangying | 5 |
#6 | Schwartz Michael | 5 |
#7 | Francis Kappler | 4 |
#8 | Annette Tobia | 3 |
#9 | Tobia Annette M | 3 |
#10 | Niwa Takeshi | 2 |
Publication | Filing date | Title |
---|---|---|
CN107184569A | Keep or improve the method for object health, happiness and/or physiological function | |
WO2009155097A1 | Natural product inhibitors of 3dg | |
WO2009126695A2 | Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes | |
WO2008045272A2 | Compositions and methods for skin lightening | |
US2010297046A1 | Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors | |
US2007021357A1 | Treatment of inflammatory conditions | |
EP1802278A2 | Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds | |
AU2005214971A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | |
CN101084235A | 3-deoxyglucosone and skin | |
US7622117B2 | 3-deoxyglucosone and skin |